We propose to use our established Neuropathology Core facilities at the Institute of Neurological Sciences at the Southern General Hospital, University of Glasgow, to facilitate and support the investigations of the University of Pennsylvania Head Injury Center into the molecular and cellular mechanisms of cellular injury and death following traumatic brain injury (TBI). We have been supported by the UPHIC Program Project grant for over 15 years and in the current application, we propose to: (1) Secure, preserve, examine and genotype brain tissue from fatally head- injured patients admitted to the managed by the Department of Neurosurgery, Glasgow (Professor G.M. Teasdale). Material from age/sex matched controls will be secured and similarly processed. This tissue, together with frozen material from human autopsy cases from our brain bank will be made available to the Investigators of Projects 1, 2 and 3 to enable them to perform cross-species comparisons and make a direct correlation of the pathobiological mechanisms of cellular death and dysfunction between animal models and humans subjects to TBI. (2) Our Core will also provide and perform the detailed histopathological assessment of the extent and pattern of cell death following experimental brain injury (in conjunction with Project 1) and evaluate the ability of novel neuroprotective strategies to protect cells following brain injury and treatment with experiment compounds (in conjunction with Project 5). (3) Finally, we will perform the morphological assessment of apoptotic/necrotic cell death in human brain-injured tissue which will be directly compared with similar patterns following experimental TBI (in conjunction with Project 3). Our expertise in neuropathological assessment following TBI will provide us with the unique opportunity to evaluate the clinical fidelity of the experimental brain injury models associated with this grant (side-by-side comparisons between animal and human tissue), and to insure the accurate histological evaluation of novel neuroprotective therapies for brain injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS008803-28A2
Application #
6370186
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
1976-08-01
Project End
2005-08-31
Budget Start
Budget End
Support Year
28
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Nariai, Hiroki; Duberstein, Susan; Shinnar, Shlomo (2018) Treatment of Epileptic Encephalopathies: Current State of the Art. J Child Neurol 33:41-54
Nariai, Hiroki; Beal, Jules; Galanopoulou, Aristea S et al. (2017) Scalp EEG Ictal gamma and beta activity during infantile spasms: Evidence of focality. Epilepsia 58:882-892
Tomasevic, Gregor; Laurer, Helmut L; Mattiasson, Gustav et al. (2012) Delayed neuromotor recovery and increased memory acquisition dysfunction following experimental brain trauma in mice lacking the DNA repair gene XPA. J Neurosurg 116:1368-78
Browne, Kevin D; Chen, Xiao-Han; Meaney, David F et al. (2011) Mild traumatic brain injury and diffuse axonal injury in swine. J Neurotrauma 28:1747-55
Tomasevic, Gregor; Raghupathi, Ramesh; Scherbel, Uwe et al. (2010) Deletion of the p53 tumor suppressor gene improves neuromotor function but does not attenuate regional neuronal cell loss following experimental brain trauma in mice. J Neurosci Res 88:3414-23
Hånell, Anders; Clausen, Fredrik; Björk, Maria et al. (2010) Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma 27:1297-309
Marklund, N; Morales, D; Clausen, F et al. (2009) Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice. Neuroscience 163:540-51
Marklund, Niklas; Bareyre, Florence M; Royo, Nicolas C et al. (2007) Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg 107:844-53
Keck, Carrie A; Thompson, Hilaire J; Pitkanen, Asla et al. (2007) The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury. Restor Neurol Neurosci 25:77-90
Serbest, Gulyeter; Burkhardt, Matthew F; Siman, Robert et al. (2007) Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice. Neurochem Res 32:2006-14

Showing the most recent 10 out of 71 publications